Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
3rd Jul 201712:45 pmRNSHolding(s) in Company
3rd Jul 201712:44 pmRNSHolding(s) in Company
30th Jun 20178:56 amRNSDirector/PDMR Shareholding
29th Jun 201711:07 amRNSResult of Meeting and Total Voting Rights
12th Jun 20178:21 amRNSResult of Placing
12th Jun 20177:01 amRNSProposed Placing
12th Jun 20177:00 amRNSInterim Results - Six Months Ended 30 April 2017
25th May 20177:00 amRNSDirectorate Changes and Possible Fundraising
13th Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 201711:50 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 201711:50 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 20178:21 amRNSPossible offer by Dolphin for FIH Group
9th Mar 201712:17 pmRNSResult of AGM
9th Mar 201710:57 amRNSAGM Statement
13th Feb 201711:31 amRNSBlock Listing Six Monthly Return
7th Feb 20172:40 pmRNSPublication of Annual Report and Notice of AGM
3rd Feb 201711:28 amRNSTransaction in Own Shares and Total Voting Rights
1st Feb 20172:09 pmRNSProposed Award of Share Options
26th Jan 20177:00 amRNSPreliminary Results - Year Ended 31 October 2016
6th Jan 201711:50 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201612:30 pmRNSForm 8.5 (EPT/NON-RI) AMENDMENT
1st Dec 201611:50 amRNSForm 8.5 (EPT/NON-RI)
30th Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
21st Nov 201612:17 pmRNSForm 8.5 (EPT/NON-RI)
2nd Nov 201611:50 amRNSForm 8.5 (EPT/NON-RI)
28th Oct 201612:27 pmRNSHolding(s) in Company
28th Oct 201612:12 pmRNSHolding(s) in Company
28th Oct 201611:03 amRNSHolding(s) in Company
28th Oct 201610:44 amRNSHolding(s) in Company
28th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20167:00 amRNSPersonnel Change
6th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
4th Oct 201611:50 amRNSForm 8.5 (EPT/NON-RI)
26th Sep 201611:49 amRNSForm 8.5 (EPT/NON-RI)
20th Sep 201611:50 amRNSForm 8.5 (EPT/NON-RI)
16th Sep 20162:19 pmRNSForm 8.5 (EPT/NON-RI)
19th Aug 201612:08 pmRNSHolding(s) in Company
12th Aug 201611:25 amRNSBlocklisting Six Monthly Return
11th Aug 201610:10 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 20167:00 amRNSDirector/PDMR Shareholding
1st Aug 20167:30 amRNSChange of Name of Nominated Adviser
28th Jul 20167:00 amRNSInterim Results - Six Months Ended 30 April 2016
21st Jul 201611:50 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 201611:23 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
9th Jun 20169:44 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 201611:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.